We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Lilly Seeks To Stay Whistleblower Suit Over Zyprexa

Law360 (October 3, 2007, 12:00 AM EDT) -- Eli Lilly & Co. is seeking to stay a whistleblower suit over charges it marketed its blockbuster anti-psychotic drug Zyprexa for off-label uses, arguing the case should be joined with a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.